Case Report: Evolution of intratumoral spatial heterogeneity assessed by [68Ga]Ga-DOTA-NOC PET/CT during dinutuximab beta therapy in pediatric high-risk neuroblastoma - Top-Institutions - MDSpire

Case Study: Changes in Intratumoral Spatial Heterogeneity Monitored by [68Ga]Ga-DOTA-NOC PET/CT During Dinutuximab Beta Treatment in Pediatric Patients with High-Risk Neuroblastoma

  • By

  • Yueran Chen

  • Qinfeng Xu

  • Haoyan Zhang

  • Yongjun Fang

  • Guoqiang Shao

  • July 21, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Princess Máxima Center for Pediatric Oncology
    Princess Máxima Center for Pediatric Oncology

    Utrecht, Netherlands

    Key Differentiators

    • Pediatric Oncology

  • #2

    Great Ormond Street Hospital (GOSH) for Children NHS Foundation Trust
    Great Ormond Street Hospital (GOSH) for Children NHS Foundation Trust

    London, United Kingdom

    Key Differentiators

    • Pediatric Oncology

Original Source(s)

Case Report: Evolution of intratumoral spatial heterogeneity assessed by [68Ga]Ga-DOTA-NOC PET/CT during dinutuximab beta therapy in pediatric high-risk neuroblastoma

  • by Yueran Chen, Qinfeng Xu, Haoyan Zhang, Yongjun Fang, Guoqiang Shao

  • July 21, 2026

Related Content

Troponin Screening and Major Cardiovascular Adverse Events During Immune Checkpoint Inhibitor Therapy

Screening Eligibility and Survival Among Patients With Lung Cancer in Korea

A double-edged sword: the role of macrophage pyroptosis-driven cytokine storm-mediated intercellular communication in tumor progression